Hólyagrák: vizsgálatok itt: Szingapúr

2 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 1/2. fázisTaking people
  Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  Where

  Singapore

  Életkor

  18 év and over

  People

  340 worldwide

  Run by

  Inhibrx Biosciences, Inc

  See details and how to joinNCT04198766
• 1/2. fázisTaking people
  A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  Where

  Singapore

  Életkor

  18 év and over

  People

  180 worldwide

  Run by

  Alentis Therapeutics AG

  See details and how to joinNCT07169734 · EU 2025-521441-24-00